# Progress Note 03 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Winston Churchill (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET001-SYN-TD
- Date: 1953-07-29
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Okafor, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Lightheaded on standing for three days. **S**

## History of present illness

Mr. Churchill is a 78-year-old man five weeks after a minor right-hemisphere lacunar stroke, on clopidogrel, atorvastatin, amlodipine 10 mg, and lisinopril 5 mg, which was added two weeks ago. For three days, during the current heat wave, he has felt lightheaded and dim-sighted for a minute or so when he stands up, worst on rising from his afternoon nap and after dinner. Yesterday he had to sit back down on the edge of the bed to avoid falling; he did not fall or lose consciousness. The symptoms go away when he sits or lies down. He has had no new weakness, numbness, change in speech, facial droop, double vision, or vertigo, and his left arm and leg are no weaker than last week. He has had no chest pain or palpitations. He admits drinking less water than advised and still has whisky and soda through the afternoon and wine at dinner. His 30-day heart monitor is still in place. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago, two weeks after lisinopril was added, during hot weather |
| Character | Lightheadedness and dimming of vision on standing; no spinning |
| Duration | About a minute each time |
| Timing | On rising, worst after his afternoon nap and after dinner |
| Severity | One near-fall without injury; no loss of consciousness |
| Modifying factors | Relieved by sitting or lying down; worse with heat, low fluid intake, and alcohol |
| Associated signs and symptoms | Denies new focal weakness, numbness, speech change, facial droop, diplopia, vertigo, chest pain, and palpitations |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired in the heat; thirsty; no fever |
| Cardiovascular | Positive | Lightheaded on standing; no chest pain, palpitations, or syncope |
| Neurological | Negative | No new weakness, numbness, speech change, facial droop, diplopia, or vertigo |
| Genitourinary | Negative | Passing less urine than usual; no dysuria |
| Gastrointestinal | Negative | No vomiting, diarrhea, or black stools |

5 systems reviewed. **S**

## Current medications

- Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Lisinopril 5 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/68 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 97% on room air; weight 78.8 kg; BMI 27.9 kg/m². All vital signs are synthetic.

Sodium: 137 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 1.12 mg/dL; eGFR: 67 mL/min/1.73 m²; Glucose: 94 mg/dL; NIH Stroke Scale: 1. All results are synthetic.

## Change since baseline

- Sodium: 139 mmol/L at baseline, 137 mmol/L at this visit **S**
- Potassium: 4.3 mmol/L at baseline, 4.6 mmol/L at this visit **S**
- Creatinine: 0.98 mg/dL at baseline, 1.12 mg/dL at this visit **S**
- eGFR: 79 mL/min/1.73 m² at baseline, 67 mL/min/1.73 m² at this visit **S**
- Glucose: 97 mg/dL at baseline, 94 mg/dL at this visit **S**
- NIH Stroke Scale: 2 at baseline, 1 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert and talkative; dry mouth |
| Orthostatic vital signs | Seated 118/68 mmHg, heart rate 76; standing at 3 minutes 96/60 mmHg, heart rate 88, with lightheadedness: a fall of 22 mmHg systolic |
| Cardiovascular | Regular rhythm; no murmur |
| Neurological | NIH Stroke Scale 1 for the same mild left arm drift as before; speech clear; no new deficit |
| Monitor check | The 30-day ambulatory ECG transmissions so far show sinus rhythm without atrial fibrillation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Orthostatic hypotension** (I95.1). A fall of 22 mmHg systolic on standing, with symptoms, after adding lisinopril to amlodipine 10 mg, made worse by heat, low fluid intake, and alcohol. The symptoms are positional and the neurological examination is unchanged, so a transient ischemic attack is unlikely. Creatinine has risen from 0.98 to 1.12 mg/dL (eGFR 67) with potassium 4.6, consistent with low volume and the new ACE inhibitor. **S**
   - Reduce amlodipine from 10 mg to 5 mg daily; continue lisinopril 5 mg.
   - Drink about 2 liters of fluid a day during the hot weather, and keep alcohol out of the afternoon.
   - Sit on the edge of the bed for a minute before standing, especially after his nap and at night.
   - Home blood pressure seated and standing each morning; bring the readings to the next visit.
2. **Essential hypertension** (I10). Seated blood pressure 118/68 mmHg today is below target at the cost of orthostatic symptoms. **S**
   - Accept a seated target below 130/80 only without orthostatic symptoms; recheck seated and standing pressures in three weeks.
3. **Lacunar stroke five weeks ago** (I69.354). No new deficit; recovery continuing with physical therapy. **S**
   - Continue clopidogrel and atorvastatin.
   - Physical therapist informed of the near-fall.

## Medication changes

- Stopped: Amlodipine 10 mg oral tablet, one tablet by mouth daily **S**
- Started: Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology
- Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome (2011), American Autonomic Society and European Federation of Autonomic Societies (Clinical Autonomic Research)

## Follow-up

- Review in three weeks as planned, with the lipid panel and monitor result. Call 911 for sudden weakness, numbness, facial droop, speech difficulty, or loss of vision, and return the same day for a fall or fainting. **S**
- Next scheduled visit 1953-08-19: eight-week stroke and blood pressure review with lipid panel and rhythm-monitor results. **S**
